Education and Training
Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos
To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: Non-euploid embryo transfer
- other: Euploid Transfer
Eligibility
Inclusion Criteria:
- Available aneuploid or mosaic embryos
- No other acceptable embryos available
- Willing to travel to Stanford for treatment
- English language fluency
Exclusion Criteria:
- Use of international donor eggs or sperm not tested according to FDA guidelines.
- Living outside the United States
- Embryos with Triploidy are not eligible for transfer in this protocol
Ages Eligible for Study
18 Years - 55 Years
Genders Eligible for Study
Female
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Alleigh Boyd, MS
408-688-9749
I'm interested